Antibacterial Potential with Molecular Docking Study against Multi-Drug Resistant Bacteria and Mycobacterium tuberculosis of Streptomycin Produced by Streptomyces atroverins, strain Askar-SH50
performed on streptomycin in order to emphasize its mode of action as an anti TB, and to determine its possible binding interactions with Mycobacterium tuberculosis enoyl-reductase InhA enzyme

